These data compellingly indicate that TP53-mutant breast tumors show a significant upregulation of KIFC1 and centrosome clustering CPC genes, as well as a concomitant overexpression of ATAD2, E2F1, and FOXM1. Here, TP53 is linked to breast neoplasm.